HBV induced HCC: Major risk factors from genetic to molecular level

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ayub, Ambreen ^a   Ashfaq, Usman Ali ^a   Haque, Asma ^a  

^a GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; CYCLIN D1; ENTECAVIR; FLICE INHIBITORY PROTEIN; FOCAL ADHESION KINASE 1; GELATINASE B; HEPATITIS B CORE ANTIGEN; HEPATITIS B VIRUS X PROTEIN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; LAMIVUDINE; LYMPHOID ENHANCER FACTOR 1; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHOTRANSFERASE; PROTEIN BCL 2; PROTEIN MCL 1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RAC1 PROTEIN; RNA H19; SCATTER FACTOR RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; STAT3 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALCOHOL LIVER DISEASE; ANTIVIRAL THERAPY; CANCER RISK; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DNA INTEGRATION; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; GENE ACTIVATION; GENETIC DISORDER; GENETIC RISK; GENOME ANALYSIS; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INSULIN RESISTANCE; LIVER CANCER; LIVER CELL CARCINOMA; METABOLIC DISORDER; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PROTEIN DEGRADATION; RADIOFREQUENCY ABLATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC THERAPY; TRANSCRIPTION REGULATION; VACCINATION; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS REPLICATION; CARCINOMA, HEPATOCELLULAR; GENETIC PREDISPOSITION; GENETICS; LIVER NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RISK FACTOR; VIROLOGY; LIVER TUMOR;

CARCINOMA, HEPATOCELLULAR; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; PREVALENCE; RISK FACTORS;

EID: 84883137078     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/810461     Document Type: Review

References (176)

1. Lin C.-L., Kao J.-H., The clinical implications of hepatitis B virus genotype: recent advances. Journal of Gastroenterology and Hepatology 2011 26 1 123 130 2-s2.0-78650770247 10.1111/j.1440-1746.2010.06541.x
2. Summers J., Three recently described animal virus models for human hepatitis B virus. Hepatology 1981 1 2 179 183 2-s2.0-0019796057
3. Stuyver L., de Gendt S., van Geyt C., Zoulim F., Fried M., Schinazi R. F., Rossau R., A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. Journal of General Virology 2000 81 1 67 74 2-s2.0-0033957572
4. Arauz-Ruiz P., Norder H., Robertson B. H., Magnius L. O., Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. Journal of General Virology 2002 83 8 2059 2073 2-s2.0-0036330525
5. Viana R., Wang R., Yu M. C., Welschinger R., Chen C.-Y., Kew M. C., Hepatitis B viral loads in southern African blacks with hepatocellular carcinoma. Journal of Medical Virology 2009 81 9 1525 1530 2-s2.0-68949156465 10.1002/jmv.21574
6. Kew M. C., Hepatocellular carcinoma in African Blacks: recent progress in etiology and pathogenesis. World Journal of Hepatology 2010 2 65 73
7. Mason CSaWS, Hepatitis B virus biology. Microbiology and Molecular Biology Reviews 2000 64 51 68
8. Wu S., Kanda T., Imazeki F., Arai M., Yonemitsu Y., Nakamoto S., Fujiwara K., Fukai K., Nomura F., Yokosuka O., Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral Immunology 2010 23 5 467 476 2-s2.0-77957743340 10.1089/vim.2010.0042
9. Di Bisceglie A. M., Hepatitis B and hepatocellular carcinoma. Hepatology 2009 49 5 S56 S60 2-s2.0-66149163340 10.1002/hep.22962
10. Liu K., Lei X.-Z., Zhao L.-S., Tang H., Liu L., Feng P., Lei B.-J., Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma. World Journal of Gastroenterology 2005 11 9 1369 1372 2-s2.0-15844397971
11. Milich D., Liang T. J., Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003 38 5 1075 1086 2-s2.0-0142151773 10.1053/jhep.2003.50453
12. Zhang Z., Torii N., Hu Z., Jacob J., Liang T. J., X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. Journal of Clinical Investigation 2001 108 10 1523 1531 2-s2.0-0035178992 10.1172/JCI200113787
13. Hu Z., Zhang Z., Kim J. W., Huang Y., Liang T. J., Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. Journal of Virology 2006 80 3 1405 1413 2-s2.0-31144454150 10.1128/JVI.80.3. 1405-1413.2006
14. Bouchard M. J., Schneider R. J., The enigmatic X gene of hepatitis B virus. Journal of Virology 2004 78 23 12725 12734 2-s2.0-8644274040 10.1128/JVI.78.23.12725-12734.2004
15. Jiang Z., Jhunjhunwala S., Liu J., Haverty P. M., Kennemer M. I., Guan Y., Lee W., Carnevali P., Stinson J., Johnson S., Diao J., Yeung S., Jubb A., Ye W., Wu T. D., Kapadia S. B., de Sauvage F. J., Gentleman R. C., Stern H. M., Seshagiri S., Pant K. P., Modrusan Z., Ballinger D. G., Zhang Z., The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Research 2012 22 4 593 601 2-s2.0-84859553856 10.1101/gr.133926.111
16. Shafritz D. A., Shouval D., Sherman H. I., Hadziyannis S. J., Kew M. C., Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. New England Journal of Medicine 1981 305 18 1067 1073 2-s2.0-0019791877
17. Tu H., Bonura C., Giannini C., Mouly H., Soussan P., Kew M., Paterlini-Bréchot P., Bréchot C., Kremsdorf D., Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Research 2001 61 21 7803 7810 2-s2.0-0035502957
18. Kremsdorf D., Soussan P., Paterlini-Brechot P., Brechot C., Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 2006 25 27 3823 3833 2-s2.0-33745517203 10.1038/sj.onc.1209559
19. Murakami Y., Saigo K., Takashima H., Minami M., Okanoue T., Bréchet C., Paterlini-Bréchot P., Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005 54 8 1162 1168 2-s2.0-22644435919 10.1136/gut.2004.054452
20. Su I.-J., Wang H.-C., Wu H.-C., Huang W.-Y., Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. Journal of Gastroenterology and Hepatology 2008 23 8 1169 1174 2-s2.0-48549088872 10.1111/j.1440-1746.2008.05348.x
21. Soussan P., Garreau F., Zylberberg H., Ferray C., Brechot C., Kremsdorf D., In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. Journal of Clinical Investigation 2000 105 1 55 60 2-s2.0-0033987575
22. Fang Z.-L., Sabin C. A., Dong B.-Q., Wei S.-C., Chen Q.-Y., Fang K.-X., Yang J.-Y., Huang J., Wang X.-Y., Harrison T. J., Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. Journal of General Virology 2008 89 11 2882 2890 2-s2.0-56349099754 10.1099/vir.0.2008/002824-0
23. Huang H.-P., Hsu H.-Y., Chen C.-L., Ni Y.-H., Wang H.-Y., Tsuei D.-J., Chiang C.-L., Tsai Y.-C., Chen H.-L., Chang M.-H., Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children. Pediatric Research 2010 67 1 90 94 2-s2.0-73449131849 10.1203/PDR.0b013e3181c1b0b7
24. Hsieh Y.-H., Su I.-J., Wang H.-C., Chang W.-W., Lei H.-Y., Lai M.-D., Chang W.-T., Huang W., Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004 25 10 2023 2032 2-s2.0-6444242588 10.1093/carcin/bgh207
25. Hsieh Y. H., Su I. J., Yen C. J., Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. Carcinogenesis 2012 34 475 485
26. Bréchot C., Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004 127 S56 S61 2-s2.0-7044260782 10.1053/j.gastro.2004.09.016
27. Chen W. N., Chen J. Y., Jiao B. Y., Lin W. S., Wu Y. L., Liu L. L., Lin X., Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion. Journal of Virology 2012 86 13533 13541 10.1128/JVI.02095-12
28. Hwang G.-Y., Lin C.-Y., Huang L.-M., Wang Y.-H., Wang J.-C., Hsu C.-T., Yang S.-S., Wu C.-C., Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. Journal of Clinical Microbiology 2003 41 12 5598 5603 2-s2.0-0347479386 10.1128/JCM.41.12.5598-5603.2003
29. Gearhart T. L., Bouchard M. J., The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. Journal of Virology 2010 84 6 2675 2686 2-s2.0-77649112712 10.1128/JVI.02196-09
30. Dandri M., Schirmacher P., Rogler C. E., Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. Journal of Virology 1996 70 8 5246 5254 2-s2.0-0029955711
31. Doria M., Klein N., Lucito R., Schneider R. J., The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. The EMBO Journal 1995 14 19 4747 4757 2-s2.0-0029147911
32. Sirma H., Weil R., Rosmorduc O., Urban S., Israël A., Kremsdorf D., Bréchot C., Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene 1998 16 16 2051 2063 2-s2.0-0032559971
33. Weil R., Sirma H., Giannini C., Kremsdorf D., Bessia C., Dargemont C., Bréchot C., Israël A., Direct association and nuclear import of the hepatitis B virus X protein with the NF- B inhibitor I B α Molecular and Cellular Biology 1999 19 9 6345 6354 2-s2.0-0032772369
34. Forgues M., Marrogi A. J., Spillare E. A., Wu C.-G., Yang Q., Yoshida M., Wang X. W., Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway. Journal of Biological Chemistry 2001 276 25 22797 22803 2-s2.0-0035933725 10.1074/jbc.M101259200
35. Zhang X., Zhang H., Ye L., Effects of hepatitis B virus X protein on the development of liver cancer. Journal of Laboratory and Clinical Medicine 2006 147 2 58 66 2-s2.0-31944438515 10.1016/j.lab.2005.10.003
36. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P., Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979 281 5733 646 650 2-s2.0-0018728052
37. Miller R. H., Robinson W. S., Common evolutionary origin of hepatitis B virus and retroviruses. Proceedings of the National Academy of Sciences of the United States of America 1986 83 8 2531 2535 2-s2.0-0343789889
38. Koike K., Moriya K., Yotsuyanagi H., Iino S., Kurokawa K., Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. Journal of Clinical Investigation 1994 94 1 44 49 2-s2.0-0028284787
39. Nakatake H., Chisaka O., Yamamoto S., Matsubara K., Koshy R., Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 1993 195 2 305 314 2-s2.0-0027326201 10.1006/viro.1993. 1381
40. Spandau D. F., Lee C.-H., Trans-activation of viral enhancers by the hepatitis B virus X protein. Journal of Virology 1988 62 2 427 434 2-s2.0-0023833938
41. Twu J.-S., Chu K., Robinson W. S., Hepatitis B virus X gene activates B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proceedings of the National Academy of Sciences of the United States of America 1989 86 13 5168 5172 2-s2.0-0342515452
42. Zahm P., Hofschneider P. H., Koshy R., The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 1988 3 2 169 177 2-s2.0-0023711995
43. Chen H.-S., Kaneko S., Girones R., Anderson R. W., Hornbuckle W. E., Tennant B. C., Cote P. J., Gerin J. L., Purcell R. H., Miller R. H., The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. Journal of Virology 1993 67 3 1218 1226 2-s2.0-0027478980
44. Kekule A. S., Lauer U., Weiss L., Luber B., Hofschneider P. H., Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993 361 6414 742 745 2-s2.0-0027409855 10.1038/361742a0
45. Kim C.-M., Koike K., Saito I., Miyamura T., Jay G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991 351 6324 317 320 2-s2.0-0025907983 10.1038/351317a0
46. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamura T., Kurokawa K., High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994 19 4 810 819 2-s2.0-0028230728 10.1016/0270-9139(94)90277-1
47. Moriarty A. M., Alexander H., Lerner R. A., Thornton G. B., Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 1985 227 4685 429 433 2-s2.0-0021917921
48. Rossner M. T., Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. Journal of Medical Virology 1992 36 2 101 117 2-s2.0-0026514186
49. Seto E., Mitchell P. J., Benedict Yen T. S., Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 1990 344 6261 72 74 2-s2.0-0025176474
50. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K., The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Japanese Journal of Cancer Research 1989 80 7 617 621 2-s2.0-0024797064
51. Li N., Grivennikov S. I., Karin M., The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011 19 4 429 431 2-s2.0-79953749145 10.1016/j.ccr.2011.03.018
52. Gearhart T. L., Bouchard M. J., The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. Journal of Virology 2010 84 6 2675 2686 2-s2.0-77649112712 10.1128/JVI.02196-09
53. Yang B., Bouchard M. J., The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. Journal of Virology 2012 86 1 313 327 2-s2.0-84855913126 10.1128/JVI.06442-11
54. Bouchard M. J., Schneider R. J., The enigmatic X gene of hepatitis B virus. Journal of Virology 2004 78 23 12725 12734 2-s2.0-8644274040 10.1128/JVI.78.23.12725-12734.2004
55. Cheong J.-H., Yi M.-K., Lin Y., Murakami S., Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. The EMBO Journal 1995 14 1 143 150 2-s2.0-0028878098
56. Haviv I., Shamay M., Doitsh G., Shaul Y., Hepatitis B virus pX targets TFIIB in transcription coactivation. Molecular and Cellular Biology 1998 18 3 1562 1569 2-s2.0-0031932893
57. Lin Y., Nomura T., Cheong J., Dorjsuren D., Iida K., Murakami S., Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. Journal of Biological Chemistry 1997 272 11 7132 7139 2-s2.0-0030989802 10.1074/jbc.272.11.7132
58. Murakami S., Cheong J., Ohno S., Matsushima K., Kaneko S., Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 1994 199 1 243 246 2-s2.0-0028274952 10.1006/viro.1994.1119
59. Byung Hyune Choi B. H. C., Choi M., Hyun Yong Jeon H. Y. J., Hyune Mo Rho H. M. R., Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter. DNA and Cell Biology 2001 20 2 75 80 2-s2.0-0035118852 10.1089/104454901750070274
60. Qadri I., Conaway J. W., Conaway R. C., Schaack J., Siddiqui A., Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 10578 10583 2-s2.0-0029743407 10.1073/pnas.93.20.10578
61. Elmore L. W., Hancock A. R., Chang S.-F., Wang X. W., Chang S., Callahan C. P., Geller D. A., Will H., Harris C. C., Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proceedings of the National Academy of Sciences of the United States of America 1997 94 26 14707 14712 2-s2.0-0031460372 10.1073/pnas.94.26.14707
62. Pan J., Duan L.-X., Sun B. S., Feitelson M. A., Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF- B. Journal of General Virology 2001 82 1 171 182 2-s2.0-0035155733
63. Nicolas M., Wolfer A., Raj K., Kummer J. A., Mill P., Van Noort M., Hui C.-C., Clevers H., Dotto G. P., Radtke F., Notch1 functions as a tumor suppressor in mouse skin. Nature Genetics 2003 33 3 416 421 2-s2.0-0037370310 10.1038/ng1099
64. Yeh C.-T., Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis. Journal of Gastroenterology and Hepatology 2000 15 4 339 341 2-s2.0-0034099196 10.1046/j.1440-1746.2000.02166.x
65. Lim K.-H., Kim K.-H., Choi S. I., Park E.-S., Park S. H., Ryu K., Park Y. K., Kwon S. Y., Yang S.-I., Lee H. C., Sung I.-K., Seong B. L., RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF- B signaling via its novel chaperoning function. PLoS ONE 2011 6 8 2-s2.0-80051703434 10.1371/journal.pone.0022258 e22258
66. Shih W.-L., Kuo M.-L., Chuang S.-E., Cheng A.-L., Doong S.-L., Hepatitis b virus x protein inhibits transforming growth factor- β -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. Journal of Biological Chemistry 2000 275 33 25858 25864 2-s2.0-0034682769 10.1074/jbc.M003578200
67. Lee Y.-H., Yun Y., HBx protein of hepatitis B virus activates Jak1-STAT signaling. Journal of Biological Chemistry 1998 273 39 25510 25515 2-s2.0-0032566516 10.1074/jbc.273.39.25510
68. Chung T.-W., Lee Y.-C., Kim C.-H., Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. The FASEB Journal 2004 18 10 1123 1125 2-s2.0-7744229935 10.1096/fj.03-1429fje
69. Bock C.-T., Toan N. L., Koeberlein B., Song L. H., Chin R., Zentgraf H., Kandolf R., Torresi J., Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of stat/socs signaling in hepatocellular carcinoma. Intervirology 2009 51 6 432 443 2-s2.0-62849115345 10.1159/000209672
70. Sun Q., Wang Y., Zhang Y., Liu F., Cheng X., Hou N., Zhao X., Yang X., Expression profiling reveals dysregulation of cellular cytoskeletal genes in HBx-induced hepatocarcinogenesis. Cancer Biology & Therapy 2007 6 5 668 674 2-s2.0-34548260790
71. Lee S.-W., Lee Y. M., Bae S.-K., Murakami S., Yun Y., Kim K.-W., Human hepatitis B virus x protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochemical and Biophysical Research Communications 2000 268 2 456 461 2-s2.0-0034673319 10.1006/bbrc.2000.2093
72. Yoo Y.-G., Na T.-Y., Seo H.-W., Seong J. K., Park C. K., Shin Y. K., Lee M.-O., Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008 27 24 3405 3413 2-s2.0-44449114668 10.1038/sj.onc.1211000
73. Xu J., Liu H., Chen L., Wang S., Zhou L., Yun X., Sun L., Wen Y., Gu J., Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology 2012 143 199 212 10.1053/j.gastro.2012.03.053
74. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061
75. Poon D., Anderson B. O., Chen L.-T., Tanaka K., Lau W. Y., Van Cutsem E., Singh H., Chow W. C., Ooi L. L., Chow P., Khin M. W., Koo W. H., Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. The Lancet Oncology 2009 10 11 1111 1118 2-s2.0-71249126197 10.1016/S1470-2045(09)70241-4
76. Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., Castagnetta L. A. M., Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Annals of the New York Academy of Sciences 2002 963 13 20 2-s2.0-0036291076
77. Gomaa A. I., Khan S. A., Toledano M. B., Waked I., Taylor-Robinson S. D., Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World Journal of Gastroenterology 2008 14 27 4300 4308 2-s2.0-55949086924 10.3748/wjg.14.4300
78. Weinberg A. G., Mize C. E., Worthen H. G., The occurence of hepatoma in the chronic form of hereditary tyrosinemia. Journal of Pediatrics 1976 88 3 434 438 2-s2.0-0017106109
79. Hashimoto E., Yatsuji S., Tobari M., Taniai M., Torii N., Tokushige K., Shiratori K., Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Journal of Gastroenterology 2009 44 19 89 95 2-s2.0-58849090967 10.1007/s00535-008-2262-x
80. Dragani T. A., Risk of HCC: genetic heterogeneity and complex genetics. Journal of Hepatology 2010 52 2 252 257 2-s2.0-75349084543 10.1016/j.jhep.2009. 11.015
81. El-Serag H. B., Tran T., Everhart J. E., Diabetes Increases the Risk of Chronic Liver Disease and Hepatocellular Carcinoma. Gastroenterology 2004 126 2 460 468 2-s2.0-0842321807 10.1053/j.gastro.2003.10.065
82. Gao C., Zhao H.-C., Li J.-T., Yao S.-K., Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World Journal of Gastroenterology 2010 16 35 4467 4475 2-s2.0-77957607698 10.3748/wjg.v16.i35.4467
83. Park E. J., Lee J. H., Yu G.-Y., He G., Ali S. R., Holzer R. G., Österreicher C. H., Takahashi H., Karin M., Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010 140 2 197 208 2-s2.0-74549167737 10.1016/j.cell.2009.12. 052
84. Yoshida K., Nakamura H., Okuda Y., Enomoto H., Kishima Y., Uyama H., Ito H., Hirasawa T., Inagaki S., Kawase I., Expression of hepatoma-derived growth factor in hepatocarcinogenesis. Journal of Gastroenterology and Hepatology 2003 18 11 1293 1301 2-s2.0-10744224307 10.1046/j.1440-1746.2003.03191.x
85. Kowdley K. V., Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004 127 S79 S86 2-s2.0-7044222320 10.1016/j.gastro.2004.09.019
86. Hung J.-H., Teng Y.-N., WangLily L. H.-C., Su I.-J., Wang C. C. C., Huang W., Lee K.-H., Lu K.-Y., Wang L.-H., Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells. PLoS ONE 2011 6 12, article e28977 2-s2.0-84055216950 10.1371/journal.pone.0028977
87. Wang L., Huang J., Jiang M., Sun L., Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. Journal of Cellular Biochemistry 2011 112 5 1286 1294 2-s2.0-79953713241 10.1002/jcb.23030
88. Patil M. A., Lee S. A., Macias E., Lam E. T., Xu C., Jones K., Ho C., Rodriguez-Puebla M., Chen X., Role of cyclin D1 as a mediator of c-Met- and B-catenin-induced hepatocarcinogenesis. Cancer Research 2009 69 1 253 261 2-s2.0-58249117627 10.1158/0008-5472.CAN-08-2514
89. Lee C.-F., Ling Z.-Q., Zhao T., Lee K.-R., Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma. World Journal of Gastroenterology 2008 14 39 6072 6077 2-s2.0-59849104114 10.3748/wjg.14.6072
90. Kim M., Lee H. C., Tsedensodnom O., Hartley R., Lim Y.-S., Yu E., Merle P., Wands J. R., Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/ β -catenin signaling pathway in hepatocellular carcinoma cells. Journal of Hepatology 2008 48 5 780 791 2-s2.0-40949086754 10.1016/j.jhep.2007.12.020
91. Iizuka N., Oka M., Tamesa T., Hamamoto Y., Yamada-Okabe H., Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. Anticancer Research 2004 24 6 4085 4089 2-s2.0-14944373311
92. Migita K., Miyazoe S., Maeda Y., Daikoku M., Abiru S., Ueki T., Yano K., Nagaoka S., Matsumoto T., Nakao K., Hamasaki K., Yatsuhashi H., Ishibashi H., Eguchi K., Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF- β 1 polymorphisms and hepatocellular carcinoma. Journal of Hepatology 2005 42 4 505 510 2-s2.0-20044377406 10.1016/j.jhep.2004.11.026
93. Zhang J., Wang W.-L., Li Q., Qiao Q., Expression of transforming growth factor- α and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World Journal of Gastroenterology 2004 10 6 830 833 2-s2.0-1842587622
94. Tian X., Li J., Ma Z.-M., Zhao C., Wan D.-F., Wen Y.-M., Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1. Journal of Experimental & Clinical Cancer Research 2009 28 1, article 58 2-s2.0-65549165472 10.1186/1756-9966-28-58
95. He Y., Zhang H., Yin J., Xie J., Tan X., Liu S., Zhang Q., Li C., Zhao J., Wang H., Cao G., IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis 2009 30 11 1916 1922 2-s2.0-70849116484 10.1093/carcin/bgp226
96. Tanaka S., Wands J. R., Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β 1-induced apoptosis. Cancer Research 1996 56 15 3391 3394 2-s2.0-0030008955
97. Segat L., Milanese M., Crovella S., Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology 2007 132 7 2618 2619 2-s2.0-34250213664 10.1053/j.gastro.2007.04.037
98. Maass T., Sfakianakis I., Staib F., Krupp M., Galle P. R., Teufel A., Microarray-based gene expression analysis of hepatocellular carcinoma. Current Genomics 2010 11 4 261 268 2-s2.0-77953669860 10.2174/138920210791233063
99. Berzsenyi M. D., Roberts S. K., Beard M. R., Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling. Antiviral Therapy 2006 11 5 541 552 2-s2.0-33747777467
100. Teufel A., Staib F., Kanzler S., Weinmann A., Schulze-Bergkamen H., Galle P. R., Genetics of hepatocellular carcinoma. World Journal of Gastroenterology 2007 13 16 2271 2282 2-s2.0-34249845990
101. Cha M.-Y., Kim C.-M., Park Y.-M., Ryu W.-S., Hepatitis B virus X protein is essential for the activation of Wnt/ β -catenin signaling in hepatoma cells. Hepatology 2004 39 6 1683 1693 2-s2.0-2542546650 10.1002/hep.20245
102. Janssen H. L. A., Higuchi H., Abdulkarim A., Gores G. J., Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. Journal of Hepatology 2003 39 3 414 420 2-s2.0-0042329166 10.1016/S0168-8278(03)00265-4
103. Zhang X., Dong N., Yin L., Cai N., Ma H., You J., Zhang H., Wang H., He R., Ye L., Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. Journal of Medical Virology 2005 77 3 374 381 2-s2.0-25844451103 10.1002/jmv.20466
104. Lu J.-W., Hsia Y., Yang W.-Y., Lin Y.-I., Li C.-C., Tsai T.-F., Chang K.-W., Shieh G. S., Tsai S.-F., Wang H.-D., Yuh C.-H., Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model. Carcinogenesis 2012 33 1 209 219 2-s2.0-84855395049 10.1093/carcin/bgr224
105. Ali M., Idrees M., Ali L., Hussain A., Ur Rehman I., Saleem S., Afzal S., Butt S., Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virology Journal 2011 8, article 102 2-s2.0-79952201087 10.1186/1743-422X-8-102
106. Chen G. G., Lai P. B. S., Chan P. K. S., Chak E. C. W., Yip J. H. Y., Ho R. L. K., Leung B. C. S., Lau W. Y., Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein. European Journal of Cancer 2001 37 13 1695 1702 2-s2.0-0034884929 10.1016/S0959-8049(01) 00182-4
107. Wu Z.-J., Zhu Y., Huang D.-R., Wang Z.-Q., Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research 2010 29 1, article 146 2-s2.0-78149493309 10.1186/1756-9966-29-146
108. Wong C.-M., Lee J. M.-F., Ching Y.-P., Jin D.-Y., Ng I. O.-L., Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Research 2003 63 22 7646 7651 2-s2.0-0344844475
109. Peng Z., Zhang Y., Gu W., Wang Z., Li D., Zhang F., Qiu G., Xie K., Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. International Journal of Oncology 2005 26 2 467 473 2-s2.0-17044423502
110. Gong Y., Cui L., Minuk G. Y., The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma. Molecular and Cellular Biochemistry 2000 207 1-2 101 104 2-s2.0-0034096282
111. Li H., Ge C., Zhao F., Yan M., Hu C., Jia D., Tian H., Zhu M., Chen T., Jiang G., Xie H., Cui Y., Gu J., Tu H., He X., Yao M., Liu Y., Li J., Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β 1 signaling in human hepatocellular carcinoma. Hepatology 2011 54 3 910 919 2-s2.0-80052015345 10.1002/hep.24479
112. Choi S. S., Omenetti A., Syn W.-K., Diehl A. M., The role of Hedgehog signaling in fibrogenic liver repair. International Journal of Biochemistry & Cell Biology 2011 43 2 238 244 2-s2.0-78651426961 10.1016/j.biocel.2010. 10.015
113. Yuan K., Lian Z., Sun B., Clayton M. M., Ng I. O. L., Feitelson M. A., Role of mir-148a in hepatitis B associated hepatocellular carcinoma. PLoS ONE 2012 7 4, article e35331 2-s2.0-84859499487 10.1371/journal.pone.0035331
114. Moghaddam S. J., Haghighi E. N., Samiee S., Shahid N., Keramati A. R., Dadgar S., Zali M. R., Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran. World Journal of Gastroenterology 2007 13 4 588 593 2-s2.0-33846796051
115. Yao L., Li F. J., Tang Z. Q., Gao S., Wu Q. Q., Smad4 expression in hepatocellular carcinoma differs by hepatitis status. Asian Pacific Journal of Cancer Prevention 2012 13 1297 1303 10.7314/APJCP.2012.13.4.1297
116. Chu P.-Y., Yeh C.-M., Hsu N. C., Chang Y.-S., Chang J.-G., Yeh K.-T., Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma. Swiss Medical Weekly 2010 140 article w13065 2-s2.0-84855451663 10.4414/smw.2010.13065
117. Nakagawa H., Maeda S., Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World Journal of Gastroenterology 2012 18 4071 4081 10.3748/wjg.v18.i31.4071
118. Mamiya T., Yamazaki K., Masugi Y., Mori T., Effendi K., Du W., Hibi T., Tanabe M., Ueda M., Takayama T., Sakamoto M., Reduced transforming growth factor- β receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Laboratory Investigation 2010 90 9 1339 1345 2-s2.0-77956100350 10.1038/labinvest.2010.105
119. Csepregi A., Ebert M. P. A., Röcken C., Schneider-Stock R., Hoffmann J., Schulz H.-U., Roessner A., Malfertheiner P., Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma. BMC Cancer 2010 10 2-s2.0-77953676683 10.1186/1471-2407-10-317 3171471
120. Hong Y. W., Ding J., Molecular signaling in hepatocellular carcinoma. Cancer Genetics 2011 8 337 348 10.1007/978-1-4419-6082-5-18
121. Haybaeck J., Zeller N., Wolf M. J., Weber A., Wagner U., Kurrer M. O., Bremer J., Iezzi G., Graf R., Clavien P.-A., Thimme R., Blum H., Nedospasov S. A., Zatloukal K., Ramzan M., Ciesek S., Pietschmann T., Marche P. N., Karin M., Kopf M., Browning J. L., Aguzzi A., Heikenwalder M., A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 2009 16 4 295 308 2-s2.0-70349568358 10.1016/j.ccr.2009.08.021
122. Sameh M. A., He R., Liver cancer stem cells. International Journal of Hepatology 2011 2011 1 5
123. Teoh N. C., Pre-"EMT"ing key processes in liver carcinogenesis: growing evidence for how malignant hepatocytes invade and conquer: commentary. Hepatology 2010 52 1 384 388 2-s2.0-77954239703 10.1002/hep.23777
124. Wong V. W.-S., Yu J., Cheng A. S.-L., Wong G. L.-H., Chan H.-Y., Chu E. S.-H., Ng E. K.-O., Chan F. K.-L., Sung J. J.-Y., Chan H. L.-Y., High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. International Journal of Cancer 2009 124 12 2766 2770 2-s2.0-65649111667 10.1002/ijc.24281
125. Arzumanyan A., Sambandam V., Clayton M., Choi S. S., Xie G., Diehl A. M., Yu D. Y., Feitelson M., Hedgehog signaling blockade delays hepatocarcinogenesis induced by Hepatitis B virus X protein (HBx). Cancer Research 2012 72 22 5912 5920 10.1158/0008-5472.CAN-12-2329
126. Yen C.-J., Lin Y.-J., Yen C.-S., Tsai H.-W., Tsai T.-F., Chang K.-Y., Huang W.-C., Lin P.-W., Chiang C.-W., Chang T.-T., Hepatitis B virus X protein upregulates mTOR signalingthrough IKK β to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One 2012 7 article e41931
127. Coulouarn C., Factor V. M., Conner E. A., Thorgeirsson S. S., Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer. Carcinogenesis 2011 32 10 1434 1440 2-s2.0-80053150159 10.1093/carcin/bgr133
128. Fan R.-H., Li J., Wu N., Chen P.-S., Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis. World Journal of Gastroenterology 2011 17 29 3420 3430 2-s2.0-80051967464 10.3748/wjg.v17.i29.3420
129. Qin Y., Liu J.-Y., Li B., Sun Z.-L., Sun Z.-F., Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis. World Journal of Gastroenterology 2004 10 9 1276 1280 2-s2.0-4444375661
130. Severi T., Ying C., Vermeesch J. R., Cassiman D., Cnops L., Verslype C., Fevery J., Arckens L., Neyts J., van Pelt J. F., Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Molecular and Cellular
131. Yu M.-W., Yang S.-Y., Pan I.-J., Lin C.-L., Liu C.-J., Liaw Y.-F., Lin S.-M., Chen P.-J., Lee S.-D., Chen C.-J., Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. Journal of the National Cancer Institute 2003 95 19 1485 1488 2-s2.0-0141763753
132. Kim M., Lee H. C., Tsedensodnom O., Hartley R., Lim Y.-S., Yu E., Merle P., Wands J. R., Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/ β -catenin signaling pathway in hepatocellular carcinoma cells. Journal of Hepatology 2008 48 5 780 791 2-s2.0-40949086754 10.1016/j.jhep.2007.12.020
133. Wieland S., Thimme R., Purcell R. H., Chisari F. V., Genomic analysis of the host response to hepatitis B virus infection. Proceedings of the National Academy of Sciences of the United States of America 2004 101 17 6669 6674 2-s2.0-2342588229 10.1073/pnas.0401771101
134. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 23 35 10.1038/nri978
135. Taylor P. R., Martinez-Pomares L., Stacey M., Lin H.-H., Brown G. D., Gordon S., Macrophage receptors and immune recognition. Annual Review of Immunology 2005 23 901 944 2-s2.0-11844254888 10.1146/annurev.immunol.23.021704. 115816
136. Kolios G., Valatas V., Kouroumalis E., Role of Kupffer cells in the pathogenesis of liver disease. World Journal of Gastroenterology 2006 12 46 7413 7420 2-s2.0-33845899370
137. Bohr V. A., Dianov G. L., Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 1999 81 1-2 155 160 2-s2.0-0032693322 10.1016/S0300-9084(99)80048-0
138. Waris G., Ahsan H., Reactive oxygen species: role in the development of cancer and various chronic conditions. Journal of Carcinogenesis 2006 5, article14 2-s2.0-33745265207 10.1186/1477-3163-5-14
139. Senba M., Nakamura T., Itakura H., Statistical analysis of relationship between iron accumulation and hepatitis B surface antigen. American Journal of Clinical Pathology 1985 84 3 340 342 2-s2.0-0021930464
140. Gonzalez-Amaro R., Garcia-Monzon C., Garcia-Buey L., Moreno-Otero R., Alonso J. L., Yague E., Pivel J. P., Lopez-Cabrera M., Fernandez-Ruiz E., Sanchez-Madrid F., Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. Journal of Experimental Medicine 1994 179 3 841 848 2-s2.0-0028153997
141. Jia G., Takahashi R., Zhang Z., Tsuji Y., Sone H., Aldo-keto reductase 1 family B7 is the gene induced in response to oxidative stress in the livers of Long-Evans Cinnamon rats. International Journal of Oncology 2006 29 4 829 838 2-s2.0-34548509753
142. Forte T. M., McCall M. R., Knowles B. B., Shore V. G., Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. The Journal of Lipid Research 1989 30 6 817 829 2-s2.0-0024311922
143. Klomp L. W. J., Lin S.-J., Yuan D. S., Klausner R. D., Culotta V. C., Gitlin J. D., Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. Journal of Biological Chemistry 1997 272 14 9221 9226 2-s2.0-0030898098 10.1074/jbc.272.14.9221
144. Entrez Gene: aTOX1 ATX1 antioxidant protein 1 homolog (yeast)
145. Liu W., Baker S. S., Baker R. D., Nowak N. J., Zhu L., Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PLoS ONE 2011 6 9, article e24363 2-s2.0-80052637451 10.1371/journal.pone.0024363
146. Boyault S., Rickman D. S., De Reyniès A., Balabaud C., Rebouissou S., Jeannot E., Hérault A., Saric J., Belghiti J., Franco D., Bioulac-Sage P., Laurent-Puig P., Zucman-Rossi J., Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007 45 1 42 52 2-s2.0-33846463379 10.1002/hep.21467
147. Aravalli R. N., Steer C. J., Cressman E. N. K., Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008 48 6 2047 2063 2-s2.0-58149376548 10.1002/hep.22580
148. Yuan T., Wei J., Luo J., Liu M., Deng S., Chen P., Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Digestive Diseases and Sciences 2012 57 2451 2457 2-s2.0-84860557136 10.1007/s10620-012-2192-6
149. Phillips S., Chokshi S., Riva A., Evans A., Williams R., Naoumov N. V., CD8+ T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. Journal of Immunology 2010 184 1 287 295 2-s2.0-73949152609 10.4049/jimmunol.0902761
150. Maini M. K., Boni C., Lee C. K., Larrubia J. R., Reignat S., Ogg G. S., King A. S., Herberg J., Gilson R., Alisa A., Williams R., Vergani D., Naoumov N. V., Ferrari C., Bertoletti A., The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection. Journal of Experimental Medicine 2000 191 8 1269 1280 2-s2.0-0034678435 10.1084/jem.191.8.1269
151. Sitia G., Aiolfi R., Di Lucia P., Mainetti M., Fiocchi A., Mingozzi F., Esposito A., Ruggeri Z. M., Chisari F. V., Iannacone M., Guidotti L. G., Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proceedings of the National Academy of Sciences of the United States of America 2012 109 E2165 E2172 10.1073/pnas.1209182109
152. Wang J., Zhao W., Cheng L., Guo M., Li D., Li X., Tan Y., Ma S., Li S., Yang Y., Chen L., Wang S., CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. Journal of Immunology 2010 185 12 7654 7662 2-s2.0-78650635187 10.4049/jimmunol.1000927
153. Welzel T. M., Graubard B. I., Zeuzem S., El-Serag H. B., Davila J. A., Mcglynn K. A., Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-medicare database. Hepatology 2011 54 2 463 471 2-s2.0-79960747094 10.1002/hep.24397
154. Wong G. L.-H., Wong V. W.-S., Choi P. C.-L., Chan A. W.-H., Chim A. M.-L., Yiu K. K.-L., Chan H.-Y., Chan F. K.-L., Sung J. J.-Y., Chan H. L.-Y., Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009 58 1 111 117 2-s2.0-58249083392 10.1136/gut.2008.157735
155. Paradis V., Zalisnski S., Chelbi E., Guedj N., Degos F., Vilgrain V., Bedossa P., Belghiti J., Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liverfibrosis: a pathological analysis. Hepatology 2009 49 3 851 859 2-s2.0-63349085247 10.1002/hep.22734
156. Cauchy F., Zalinski S., Dokmak S., Fuks D., Farges O., Castera L., Paradis V., Belghiti J., Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. British Journal of Surgery 2013 100 113 121 10.1002/bjs.8963
157. Turati F., Talamini R., Pelucchi C., Polesel J., Franceschi S., Crispo A., Izzo F., la Vecchia C., Boffetta P., Montella M., Metabolic syndrome and hepatocellular carcinoma risk. British Journal of Cancer 2013 108 222 228 10.1038/bjc.2012.492
158. Werle-Lapostolle B., Bowden S., Locarnini S., Wursthorn K., Petersen J., Lau G., Trepo C., Marcellin P., Goodman Z., Delaney W. E. IV, Xiong S., Brosgart C. L., Chen S.-S., Gibbs C. S., Zoulim F., Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004 126 7 1750 1758 2-s2.0-2942532722 10.1053/j.gastro.2004.03.018
159. Laras A., Koskinas J., Dimou E., Kostamena A., Hadziyannis S. J., Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006 44 3 694 702 2-s2.0-33748939050 10.1002/hep.21299
160. Abraham T. M., Loeb D. D., The topology of hepatitis B virus pregenomic RNA promotes its replication. Journal of Virology 2007 81 21 11577 11584 2-s2.0-35448984203 10.1128/JVI.01414-07
161. Chong C.-L., Chen M.-L., Wu Y.-C., Tsai K.-N., Huang C.-C., Hu C.-P., Jeng K.-S., Chou Y.-C., Chang C., Dynamics of HBV cccDNA expression and transcription in different cell growth phase. Journal of Biomedical Science 2011 18 1, article 96 2-s2.0-84855170717 10.1186/1423-0127-18-96
162. Wursthorn K., Lutgehetmann M., Dandri M., Volz T., Buggisch P., Zollner B., Longerich T., Schirmacher P., Metzler F., Zankel M., Fischer C., Currie G., Brosgart C., Petersen J., Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006 44 3 675 684 2-s2.0-33748929265 10.1002/hep.21282
163. Chan H. L.-Y., Wong V. W.-S., Tse A. M.-L., Tse C.-H., Chim A. M.-L., Chan H.-Y., Wong G. L.-H., Sung J. J.-Y., Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clinical Gastroenterology and Hepatology 2007 5 12 1462 1468 2-s2.0-36549058611 10.1016/j.cgh.2007.09.005
164. van Bömmel F., Zöllner B., Sarrazin C., Spengler U., Hüppe D., Möller B., Feucht H.-H., Wiedenmann B., Berg T., Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology 2006 44 2 318 325 2-s2.0-33747041958 10.1002/hep.21253
165. Hosaka T., Suzuki F., Kobayashi M., Hirakawa M., Kawamura Y., Yatsuji H., Sezaki H., Akuta N., Suzuki Y., Saitoh S., Arase Y., Ikeda K., Kobayashi M., Kumada H., HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy. Liver International 2010 30 10 1461 1470 2-s2.0-79951651043 10.1111/j.1478-3231.2010.02344.x
166. Liver EAftSot: novel therapeutic approaches may cure chronic HBV infection. Novel Therapeutic Approaches May Cure Chronic HBV Infection 2013 Rockville, Md, USA ScienceDaily
167. Lin S.-M., Lin C.-J., Hsu C.-W., Tai D.-I., Sheen I.-S., Lin D.-Y., Liaw Y.-F., Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 2004 100 2 376 382 2-s2.0-0346093899 10.1002/cncr.20004
168. Peters M. G., Hann H. W., Martin P., Heathcote E. J., Buggisch P., Rubin R., Bourliere M., Kowdley K., Trepo C., Gray D. F., Sullivan M., Kleber K., Ebrahimi R., Xiong S., Brosgart C. L., Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 2004 126 1 91 101 2-s2.0-9144271733 10.1053/j.gastro.2003.10.051
169. Fung S. K., Andreone P., Han S. H., Rajender Reddy K., Regev A., Keeffe E. B., Hussain M., Cursaro C., Richtmyer P., Marrero J. A., Lok A. S. F., Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. Journal of Hepatology 2005 43 6 937 943 2-s2.0-27744510332 10.1016/j.jhep.2005.05.037
170. Huynh H., Molecularly targeted therapy in hepatocellular carcinoma. Biochemical Pharmacology 2010 80 5 550 560 2-s2.0-77954218447 10.1016/j.bcp.2010.03.034
171. Villanueva A., Llovet J. M., Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011 140 5 1410 1426 2-s2.0-79955433548 10.1053/j.gastro.2011.03.006
172. Frenette C., Gish R., Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications. World Journal of Gastroenterology 2012 18 6 498 506 2-s2.0-84857020475 10.3748/wjg.v18.i6.498
173. Johnson P. J., Non-surgical treatment of hepatocellular carcinoma. HPB 2005 7 1 50 55 2-s2.0-15844428989 10.1080/13651820410024076
174. Curley S. A., Stuart K. E., Schwartz J. M., Carithers R. L., Nonsurgical Therapies for Localized Hepatocellular Carcinoma: Radiofrequency Ablation, Percutaneous Ethanol Injection, Thermal Ablation, and Cryoablation 2012 Baltimore, Md, USA Wolters Kluwer Health
175. Curley S. A., Stuart K. E., Schwartz J. M., Carithers R. L., Nonsurgical Therapies for Localized Hepatocellular Carcinoma: Radiofrequency Ablation, Percutaneous Ethanol Injection, Thermal Ablation, and cryoablation 2013 Baltimore, Md, USA Wolters Kluwer Health Solution
176. Madalinski K., Recent advances in hepatitis B vaccination. Hepatitis B Annual 2008 5 1 51 65 2-s2.0-77953464673 10.4103/0972-9747.58805